ODDB.org: Open Drug Database

Labatec Pharma SA - Systen Sequi, patch transdermique (emballage combiné)

Swissmedic Registration	54716	Sequence	01
Product name	Systen Sequi	Description	patch transdermique (emballage combiné)
ATC-Classification	G03FA01	ATC-Description	Norethisterone and Estrogen
Introduction of Sequence	24.12.1998

Composition

I) phase II emplâtre: estradiolum 3.1 mg ut estradiolum hemihydricum 3.2 mg, guari gummi, isooctyl acrylate/vinyl acetate copolymer, matériel du support: poly(ethylenis terephthalas), ad praeparationem pro 16 cm² cum liberatione 50 µg/24 h. II) phase II emplâtre: estradiolum 3.1 mg ut estradiolum hemihydricum 3.2 mg, norethisteroni acetas 11.2 mg, guari gummi, isooctyl acrylate/vinyl acetate copolymer, matériel du support: poly(ethylenis terephthalas), ad praeparationem pro 16 cm² cum liberatione 50 µg/24 h et 170 µg/24 h.

Packungsbestandteile

Label

Galenic Form

patch transdermique (emballage combiné)

Active Agent	Dose
Estradiol	3.1 mg

BAG: Active Agent	Dose
Estradiol Hemihydrate	3.2 mg
Norethisterone Acetate	11.2 mg

Inactive agents	Dose	additional_information
Ad Praeparationem	16 cm
Cum Liberatione	50µg / 24h
Guari Gummi
Isooctyl Acrylate/vinyl Acetate Copolymer
Poly(Ethylenis Terephthalas)		matériel du support

Label

Galenic Form

patch transdermique (emballage combiné)

Active Agent	Dose
Estradiol	3.1 mg
Norethisterone Acetate	11.2 mg

BAG: Active Agent	Dose
Estradiol Hemihydrate	3.2 mg
Norethisterone Acetate	11.2 mg

Inactive agents	Dose	additional_information
Ad Praeparationem	16 cm
Cum Liberatione	50µg / 24h et 170 µg/24 h
Guari Gummi
Isooctyl Acrylate/vinyl Acetate Copolymer
Poly(Ethylenis Terephthalas)		matériel du support

Package number	Package Size	EFP	CP	Category	SL	Out of trade (MedRef)
028	8 plaster(s)	7.66	17.55	B	SL	Yes

2025	©ywesee GmbH